Hydrophilic Foam Cell Size Control for Wound Exudate Management

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current hydrophilic foam materials used in wound dressings lack optimal liquid handling capabilities, particularly in terms of absorption speed and capacity, due to inconsistent foam cell sizes, which affect their performance in managing wound exudate.

Innovation Solution

Incorporating nucleating particles at a concentration of 5-25% by weight into the foam manufacturing process to control and reduce foam cell size to 0.01 mm² or less, improving homogeneity and enhancing liquid absorption and spreading properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If standard foam manufacturing processes are used, then foam production is simple and cost-effective, but foam cell size is inconsistent and difficult to control

Engineering Contradiction:
Improvefoam cell size controlVSAvoidfoam manufacturing process
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

Nucleating particles are introduced as intermediary substances during foam manufacturing to mediate and control foam cell formation. These particles serve as nucleation sites that guide bubble formation, resulting in consistent and controlled foam cell sizes while maintaining the simplicity of the overall manufacturing process

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention controls foam cell size by changing the parameter of nucleation site density through the addition of nucleating particles. By adjusting the concentration and size distribution of these particles, the foam cell size and uniformity can be precisely controlled without complicating the manufacturing process

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If foam cell size is reduced to improve absorption capacity, then liquid absorption speed and capacity increase, but manufacturing control becomes more difficult

Engineering Contradiction:
Improveliquid absorption capacityVSAvoidfoam cell size consistency
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

Nucleating particles act as intermediaries that enable precise control over foam cell size reduction. These particles provide numerous nucleation sites that facilitate the formation of many small, uniform cells, thereby increasing liquid absorption capacity while maintaining manufacturing consistency

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention utilizes porous nucleating particles that facilitate controlled foam cell formation. The porous structure of these particles provides extensive surface area for nucleation, enabling consistent production of small foam cells with high liquid absorption capacity

Inventive Principle:
Principle #31Porous materials

3Ease of operation

If foam cell size is made uniform to improve liquid spreading, then liquid handling capability improves, but process control requirements increase

Engineering Contradiction:
Improveliquid spreading capabilityVSAvoidprocess control
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

Nucleating particles serve as intermediaries that naturally promote uniform foam cell formation during the foaming process. Their presence ensures consistent cell size distribution throughout the foam, improving liquid spreading capability without requiring complex process control mechanisms

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The nucleating particles enable the foam system to self-organize into uniform cell structures during manufacturing. The particles automatically distribute and guide bubble formation, resulting in homogeneous foam cell sizes and improved liquid handling properties without additional process intervention

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting hydrophilic polyurethane foam exhibits improved fluid absorption speed and capacity, with at least 85% of foam cells having a uniform small size, leading to increased absorption efficiency and reduced foam stiffness, making it suitable for medical applications.

Implementation Method 1

comprising nucleating particles present at a concentration of from 5 to 25 % by weight of said foam material... at least 85% of all foam cells in said foam material have an average cell size of 0.01 mm²

Methodology Applied
Scientific EffectNucleation: Nucleation

Implementation Method 2

hydrophilic materials are used in wound dressings to absorb and retain wound fluids... hydrophilic open-cell polyurethane foams

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Data Source

PatentEP3634505B1Foam in wound treatment
Publication Date: 2022.12.28 MOLNLYCKE HEALTH CARE AB
  • EP3634505B1 patent drawingFigure 1~2b
  • EP3634505B1 patent drawingFigure 2c~2d
  • EP3634505B1 patent drawingFigure 3~4

AI summary

The present invention relates to a hydrophilic foam material, which is of particular use in wound treatment, and toa method for producing said hydrophilic foam material.The hydrophilic foam material comprises nucleating particles, wherein at least 85% of all foam cells in said foam material have an average cell size of 0.01 mm 2 or less.